Literature DB >> 32540873

Identification of barriers to safe opioid prescribing in primary care: a qualitative analysis of field notes collected through academic detailing.

Christopher D Saffore1, Sarette T Tilton2, Stephanie Y Crawford1, Michael A Fischer3, Todd A Lee1, A Simon Pickard1, Lisa K Sharp1.   

Abstract

BACKGROUND: Understanding barriers to safe opioid prescribing in primary care is critical amid the epidemic of prescription opioid abuse, misuse, and overdose in the US. Educational outreach strategies, such as academic detailing (AD), provide a forum for identification of barriers to, and strategies to facilitate, safe opioid prescribing in primary care. AIM: To identify barriers to safe opioid prescribing among primary care providers (PCPs) through AD. DESIGN AND
SETTING: Qualitative analysis of data was collected through an existing AD intervention to improve safe opioid prescribing in primary care. The AD intervention was delivered from June 2018 to August 2018 to licensed PCPs with prescriptive authority within a large independent health system in the metropolitan Chicagoland area.
METHOD: The AD intervention involved visits by trained detailers to PCPs who contemporaneously documented details from each visit via field notes. Using qualitative analysis, field notes were analysed to identify recurring themes related to opioid prescribing barriers.
RESULTS: Detailer-entered field notes from 186 AD visits with PCPs were analysed. Barriers to safe opioid prescribing were organised into six themes: 1) gaps in knowledge; 2) lack of prescription monitoring programme (PMP) utilisation; 3) patient pressures to prescribe opioids; 4) insurance coverage policies; 5) provider beliefs; and 6) health system pain management practices.
CONCLUSION: Barriers to safe opioid prescribing in primary care, identified through AD visits among this large group of PCPs, support the need for continued efforts to enhance pain-management education, maximise PMP utilisation, and increase access to, and affordability of, non-opioid treatments. © British Journal of General Practice 2020.

Entities:  

Keywords:  academic detailing; opioids; primary health care; qualitative research

Year:  2020        PMID: 32540873      PMCID: PMC7299548          DOI: 10.3399/bjgp20X711737

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  44 in total

1.  The influence of prescription monitoring programs on chronic pain management.

Authors:  Jing Wang; Paul J Christo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

2.  Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.

Authors:  Lainie Rutkow; Lydia Turner; Eleanor Lucas; Catherine Hwang; G Caleb Alexander
Journal:  Health Aff (Millwood)       Date:  2015-03       Impact factor: 6.301

3.  Pain education in North American medical schools.

Authors:  Lina Mezei; Beth B Murinson
Journal:  J Pain       Date:  2011-09-25       Impact factor: 5.820

4.  Trump declares opioid public health emergency but no extra money.

Authors:  Bob Roehr
Journal:  BMJ       Date:  2017-10-27

5.  States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees.

Authors:  Hefei Wen; Bruce R Schackman; Brandon Aden; Yuhua Bao
Journal:  Health Aff (Millwood)       Date:  2017-04-01       Impact factor: 6.301

6.  A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol.

Authors:  Karen E Lasser; Christopher Shanahan; Victoria Parker; Donna Beers; Ziming Xuan; Orlaith Heymann; Allison Lange; Jane M Liebschutz
Journal:  J Subst Abuse Treat       Date:  2015-07-15

7.  Characteristics of state prescription drug monitoring programs: a state-by-state survey.

Authors:  A Travis Manasco; Christopher Griggs; Rebecca Leeds; Breanne K Langlois; Alan H Breaud; Patricia M Mitchell; Scott G Weiner
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-04-08       Impact factor: 2.890

8.  Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report.

Authors:  Kurt Kroenke; Daniel P Alford; Charles Argoff; Bernard Canlas; Edward Covington; Joseph W Frank; Karl J Haake; Steven Hanling; W Michael Hooten; Stefan G Kertesz; Richard L Kravitz; Erin E Krebs; Steven P Stanos; Mark Sullivan
Journal:  Pain Med       Date:  2019-04-01       Impact factor: 3.750

9.  Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco.

Authors:  Emily Behar; Christopher Rowe; Glenn-Milo Santos; Nina Santos; Phillip O Coffin
Journal:  Fam Med       Date:  2017-02       Impact factor: 1.756

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more
  3 in total

1.  Feasibility and acceptability of virtual academic detailing on opioid prescribing.

Authors:  Mary H Smart; Monika Rao Mandava; Todd A Lee; A Simon Pickard
Journal:  Int J Med Inform       Date:  2020-12-25       Impact factor: 4.046

2.  Determinants of long-term opioid prescribing in an urban population: A cross-sectional study.

Authors:  Michael Naughton; Patrick Redmond; Stevo Durbaba; Mark Ashworth; Mariam Molokhia
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

3.  Development of a measure of prescriber satisfaction with academic detailing: the PSAD.

Authors:  Andrea L Monteiro; Mary Smart; Christopher D Saffore; Todd A Lee; Sarette T Tilton; Michael A Fischer; A Simon Pickard
Journal:  Drugs Context       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.